Domestic

In the U.S., 21 Clinical Research Consortium for Spinocerebellar Ataxia institutions will participate in Aim 1 of this study. Those include:

Columbia University

Emory University

Houston Methodist Research Institute*

Johns Hopkins University

Harvard University/Massachusetts General Hospital

Northwestern University

Ohio State University

Stanford University

University of Alabama Birmingham

University of California Los Angeles

University of California San Francisco

University of Colorado

University of Chicago

University of Florida

University of Iowa

University of Michigan

University of Minnesota

University of Pennsylvania

University of Rochester Medical Center

University of Texas Southwestern Medical Center

University of South Florida

*Houston Methodist is the coordinating site for the study.

The University of Minnesota, Johns Hopkins University, Massachusetts General Hospital/Harvard Medical School, and the University of Florida will conduct Magnetic Resonance Imaging/MRS studies of Aim 2.

International

The European Ataxia Study Group (EASG) is the major European multinational consortium formed to conduct clinical research on ataxia. EASG comprises more than 50 ataxia investigators from institutions across Europe and even a few in northern Africa. The University Hospital of Bonn Bonn, Germany and the Brain & Spine Institute at the Hôpital Pitié Salpêtrière in Paris, France will serve as the lead coordinating centers for the European institutions and will conduct the Magnetic Resonance Imaging/MRS studies of Aim 2 in Europe. They will receive referrals from all European investigators.

University Hospital of Bonn, Bonn, Germany

Sorbonne Universités, Université Pierre et Marie Curie (UPMC), Brain & Spine Institute (ICM), Hôpital Pitié Salpêtrière, Paris, France